Table 1.
Patient's clinical data
| Feature | Carotids (n = 38) | MCA (n = 20) | Coronaries (n = 32) | P-value |
| Age (Mean ± SD) | 67 ± 15* | 69 ± 15† | 52.3 ± 10.8*† | 0.000 |
| Sex (♂/♀) | 25/13 | 14/6 | 25/6 | NS |
| WBC × 109/L (Mean ± SD) | 12.3 ± 10.0 | 10.9 ± 6.1 | 7.6 ± 2.1 | NS |
| Glucose (Mean ± SD) (mmol/l) | 6.7 ± 2.0 | 9,1 ± 5,4† | 5.7 ± 0.9† | 0.026 |
| Total cholesterol (Mean ± SD) (mmol/l) | 3.4 ± 1.0* | 4.6 ± 1.7 | 5.3 ± 2.0* | 0.003 |
| HTA n, (%) | 15 (39.5) | 13 (65) | 5 (16.1) | 0.001 |
| DM n, (%) | 8 (21.1) | 6 (30) | 4 (12.9) | NS |
| DLP n, (%) | 9 (23.7) | 6 (30) | 15 (48.4) | NS |
| Smoking n, (%) | 9 (23.7) | 11 (55) | 23 (74.2) | 0.000 |
| Alcohol abuse n, (%) | 8 (21.1) | 5 (25) | 14 (45.2) | NS |
| CAD n, (%) | 8 (22.2) | 5 (25) | 10 (32.3) | NS |
| Statins n, (%) | 5 (20.8) | 2 (10) | 9 (29) | NS |
| Antiplatelets n, (%) | 4 (16.7) | 6 (30) | 4 (12.9) | NS |
| Rasb n, (%) | 9 (37.5) | 6 (30) | 12 (38.7) | NS |
MCA, middle cerebral arteries; WBC, white blood cells; HTA, hypertension; DM, diabetes mellitus; DLP, dyslipemia; CAD, coronary artery disease; Rasb, renin angiotensin system blockers;
*† Statistic significant between these groups; NS, not significant